Sanofi (NASDAQ:SNY) plans to continue expanding in China as it looks to generate double-digit sales growth in the country over the next five years. The French company intends to add four factories to six existing plants in order to boost production of pharmaceuticals, vaccines, and consumer health-care and animal-care products. Sanofi is also on the lookout for acquisitions.